キャンバスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/07/30 | 1,000 | 1,014 | 982 | 1,009 | +24 | +2.4% | 215,100 |
| 2025/07/29 | 996 | 1,000 | 985 | 985 | -9 | -0.9% | 175,300 |
| 2025/07/28 | 1,005 | 1,009 | 994 | 994 | -4 | -0.4% | 145,000 |
| 2025/07/25 | 1,011 | 1,014 | 995 | 998 | -17 | -1.7% | 216,200 |
| 2025/07/24 | 1,010 | 1,022 | 997 | 1,015 | +20 | +2% | 181,700 |
| 2025/07/23 | 990 | 1,026 | 990 | 995 | +20 | +2.1% | 313,000 |
| 2025/07/22 | 999 | 1,013 | 969 | 975 | -29 | -2.9% | 387,500 |
| 2025/07/18 | 1,032 | 1,048 | 1,003 | 1,004 | -18 | -1.8% | 186,300 |
| 2025/07/17 | 1,015 | 1,038 | 1,015 | 1,022 | +9 | +0.9% | 146,800 |
| 2025/07/16 | 1,027 | 1,033 | 1,012 | 1,013 | -22 | -2.1% | 168,500 |
| 2025/07/15 | 1,075 | 1,084 | 1,026 | 1,035 | -29 | -2.7% | 326,500 |
| 2025/07/14 | 1,025 | 1,077 | 1,025 | 1,064 | +21 | +2% | 276,400 |
| 2025/07/11 | 1,010 | 1,058 | 1,010 | 1,043 | +31 | +3.1% | 308,200 |
| 2025/07/10 | 1,006 | 1,028 | 997 | 1,012 | +6 | +0.6% | 210,100 |
| 2025/07/09 | 1,009 | 1,028 | 1,004 | 1,006 | -8 | -0.8% | 192,400 |
| 2025/07/08 | 1,007 | 1,021 | 997 | 1,014 | -4 | -0.4% | 195,500 |
| 2025/07/07 | 1,012 | 1,033 | 1,001 | 1,018 | +1 | +0.1% | 218,800 |
| 2025/07/04 | 1,025 | 1,043 | 1,012 | 1,017 | -20 | -1.9% | 242,300 |
| 2025/07/03 | 1,017 | 1,037 | 995 | 1,037 | +23 | +2.3% | 283,100 |
| 2025/07/02 | 1,039 | 1,070 | 1,010 | 1,014 | -54 | -5.1% | 480,200 |
| 2025/07/01 | 1,170 | 1,178 | 1,063 | 1,068 | -127 | -10.6% | 859,500 |
| 2025/06/30 | 1,063 | 1,229 | 1,055 | 1,195 | +107 | +9.8% | 1,224,200 |
| 2025/06/27 | 1,100 | 1,128 | 1,053 | 1,088 | -6 | -0.5% | 854,600 |
| 2025/06/26 | 1,058 | 1,142 | 1,057 | 1,094 | +6 | +0.6% | 1,995,500 |
| 2025/06/25 | 1,070 | 1,088 | 1,010 | 1,088 | +150 | +16% | 1,343,600 |
| 2025/06/24 | 939 | 948 | 934 | 938 | +14 | +1.5% | 189,400 |
| 2025/06/23 | 953 | 953 | 909 | 924 | -42 | -4.3% | 430,300 |
| 2025/06/20 | 955 | 1,000 | 952 | 966 | +14 | +1.5% | 471,700 |
| 2025/06/19 | 968 | 996 | 931 | 952 | -7 | -0.7% | 409,700 |
| 2025/06/18 | 962 | 979 | 955 | 959 | ±0 | ±0% | 228,600 |
| 2025/06/17 | 971 | 984 | 953 | 959 | -10 | -1% | 206,300 |
| 2025/06/16 | 931 | 1,020 | 929 | 969 | +34 | +3.6% | 571,800 |
| 2025/06/13 | 972 | 979 | 926 | 935 | -22 | -2.3% | 377,600 |
| 2025/06/12 | 966 | 986 | 950 | 957 | -8 | -0.8% | 290,800 |
| 2025/06/11 | 954 | 989 | 951 | 965 | +11 | +1.2% | 298,500 |
| 2025/06/10 | 949 | 965 | 938 | 954 | +3 | +0.3% | 223,200 |
| 2025/06/09 | 933 | 955 | 925 | 951 | +19 | +2% | 316,400 |
| 2025/06/06 | 940 | 954 | 926 | 932 | -21 | -2.2% | 338,800 |
| 2025/06/05 | 989 | 995 | 947 | 953 | -30 | -3.1% | 441,000 |
| 2025/06/04 | 972 | 1,003 | 964 | 983 | +11 | +1.1% | 352,700 |
| 2025/06/03 | 982 | 991 | 958 | 972 | -3 | -0.3% | 445,700 |
| 2025/06/02 | 1,015 | 1,018 | 951 | 975 | -32 | -3.2% | 561,900 |
| 2025/05/30 | 1,028 | 1,045 | 995 | 1,007 | -26 | -2.5% | 616,200 |
| 2025/05/29 | 1,063 | 1,070 | 1,012 | 1,033 | -38 | -3.5% | 659,400 |
| 2025/05/28 | 1,167 | 1,174 | 1,064 | 1,071 | -99 | -8.5% | 818,000 |
| 2025/05/27 | 1,163 | 1,194 | 1,160 | 1,170 | -23 | -1.9% | 412,900 |
| 2025/05/26 | 1,255 | 1,279 | 1,190 | 1,193 | -88 | -6.9% | 664,300 |
| 2025/05/23 | 1,305 | 1,415 | 1,233 | 1,281 | -1 | -0.1% | 908,600 |
| 2025/05/22 | 1,342 | 1,350 | 1,260 | 1,282 | -120 | -8.6% | 1,114,400 |
| 2025/05/21 | 1,273 | 1,430 | 1,224 | 1,402 | +167 | +13.5% | 1,430,600 |
51～
100
件表示中 / 3802件
類似銘柄と比較する
現在ご覧いただいている「ＣＡＮＢＡＳ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ＣＡＮＢＡＳ | 101,900円 | - | - | 0.00% | - | 6.90倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
| レナサイエンス | 216,900円 | -14.4% | - | 0.00% | - | 16.03倍 |
|
東北大発創薬ベンチャー。創業者の宮田同大教授が発見した低分子化合物を使い治療薬を開発 |
| オンコリス | 78,300円 | +3771.0% | - | 0.00% | - | 14.04倍 |
|
腫瘍溶解ウイルス食道がん治療薬「テロメライシン」開発が柱。導出神経難病薬は米国治験中 |
| 扶桑薬 | 211,900円 | +1.6% | -12.7% | 4.25% | 7.87倍 | 0.55倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| ステムリム | 28,900円 | - | - | 0.00% | - | 3.06倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
市場注目の銘柄
チャート関連のコラム
